ZipBio
PrivateLast Round
Seed
Sep 5, 2024
Total Funding Raised
$4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ZipBio is a biotechnology company that develops gene therapies and biologics by leveraging generative AI to create compact, multi-specific, and logic-gated therapeutic molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZipBio Comparables
Compare ZipBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DenovAI Biotech | 83% | |
| Cassidy Bio | 82% | |
| AI Proteins | 79% | |
ZipBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2024 |
Key People
Founding team and executive leadership
ZipBio Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 725% MoM, from 228 to 1.9K.
- Sep 5, 2024
$4M round led by NFX
ZipBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ZipBio's valuation, stock price, and market status.